Bessemer Group Inc Pfizer Inc Transaction History

Bessemer Group Inc

$56.7 Billion
Q2 2024

A detailed history of Bessemer Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bessemer Group Inc holds 148,920 shares of PFE stock, worth $4.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

148,920

Previous 142,346 4.62%

Holding current value

$4.43 Million

Previous $3.95 Million 5.47%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $166,059 - $194,590	6,574 Added 4.62%	148,920 $4.17 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $791,198 - $908,548	-30,560 Reduced 17.67%	142,346 $3.95 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $1.33 Million - $1.73 Million	-51,022 Reduced 22.79%	172,906 $4.98 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $451,474 - $527,728	-14,069 Reduced 5.91%	223,928 $7.43 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $772,498 - $893,762	21,387 Added 9.87%	237,997 $8.73 Million
Q1 2023 May 10, 2023	SELL	$39.39 - $51.28 $303,381 - $394,958	-7,702 Reduced 3.43%	216,610 $8.84 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $521,958 - $681,359	-12,502 Reduced 5.28%	224,312 $11.5 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $575,268 - $702,259	13,146 Added 5.88%	236,814 $10.4 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $225,437 - $267,298	-4,845 Reduced 2.12%	223,668 $11.7 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $1.27 Million - $1.58 Million	27,844 Added 13.88%	228,513 $11.8 Million
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $1.2 Million - $1.77 Million	28,928 Added 16.84%	200,669 $11.8 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $13,227 - $16,991	-337 Reduced 0.2%	171,741 $7.39 Million
Q2 2021 Aug 06, 2021	SELL	$35.91 - $40.68 $26,824 - $30,387	-747 Reduced 0.43%	172,078 $6.74 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $1.09 Million - $1.23 Million	-32,588 Reduced 15.86%	172,825 $6.26 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $171,901 - $218,588	-5,136 Reduced 2.44%	205,413 $7.56 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $2.6 Million - $3.05 Million	-81,822 Reduced 27.99%	210,549 $7.73 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $2.65 Million - $3.22 Million	88,115 Added 43.14%	292,371 $9.56 Million
Q1 2020 Apr 30, 2020	BUY	$27.03 - $38.62 $521,922 - $745,713	19,309 Added 10.44%	204,256 $6.67 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $781,389 - $886,776	23,736 Added 14.72%	184,947 $7.25 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $276 Million - $358 Million	-8,486,752 Reduced 98.14%	161,211 $5.79 Million
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $866,256 - $972,606	-23,425 Reduced 0.27%	8,647,963 $375 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $1.34 Million - $1.47 Million	35,740 Added 0.41%	8,671,388 $368 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $87.3 Million - $99.5 Million	2,269,008 Added 35.64%	8,635,648 $377 Million
Q3 2018 Nov 06, 2018	BUY	$34.47 - $41.81 $214 Million - $259 Million	6,205,282 Added 3845.66%	6,366,640 $281 Million
Q2 2018 Jul 25, 2018	BUY	$32.98 - $35.16 $606,271 - $646,346	18,383 Added 12.86%	161,358 $5.86 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $17 Million - $19.8 Million	-533,513 Reduced 78.87%	142,975 $5.08 Million
Q4 2017 Jan 30, 2018	SELL	$33.26 - $35.29 $16.5 Million - $17.6 Million	-497,524 Reduced 42.38%	676,488 $24.5 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $36.4 Million - $40.1 Million	1,174,012	1,174,012 $41.9 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Pfizer Inc Transaction History